Research & Development Pipeline
Area
Asset/ Partner
Indication
Development
Pre-clinical
Clinical
Regulatory Submission
Approved²
Oncology
Anagrelide
Solid tumours with increased platelet levels
Central Nervous System
ZolpiMist™ ¹
Insomnia
Sumatriptan
Migraine
Medical Grade Cannabis
Cann Pharma
Drug resistant epilepsy, melonoma, motion sickness
Development Partnership
Sanofi
Not disclosed
¹Suda holds the license to ZolpMist outside of North America
²ZolpMist has been approved by the TGA & the FDA
²ZolpMist has been approved by the TGA & the FDA